If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Aim: 

To assess the regression of liver fibrosis after interferon (IFN) treatment in patients with chronic hepatitis C, liver stiffness (LS) was measured repeatedly and the factors associated with reduction of LS were assessed. Methods: 

LS was measured by transient elastography before treatment, at end of treatment (EOT), and 1 year and 2 years after EOT in 145 patients with chronic hepatitis C treated by IFN with or without ribavirin. Results: 

In the patients with sustained virological response (SVR) (n = 93) and relapsers (n = 28), LS significantly decreased at EOT (median, 5.4 [interquartile range, 4.0–8.6] kilopascals [kPa], P < 0.0001 and 6.8 [4.5–8.9] kPa, P = 0.0023) and 1 year after EOT (5.3 [4.2–7.0] kPa, P < 0.0001 and 6.8 [4.5–9.3] kPa, P = 0.0204) compared with baseline (8.0 [5.0–11.9] kPa and 10.6 [7.0–16.6] kPa). In SVR patients, LS significantly decreased 2 years after EOT (5.3 [4.1–6.3] kPa) compared with baseline (P < 0.0001) and LS at EOT (P = 0.0034). Two points or greater reduction of deduced stage at last LS measurement was observed in 78% of SVR patients, 59% of relapsers and 15% of patients with non-virological response whose pretreatment deduced stages were F3–F4. Fibrosis stage, hyaluronic acid levels, duration of treatment, response to treatment and alanine aminotransferase levels were associated with a 2-point or greater decrease of deduced fibrosis stage. Conclusion: 

IFN treatment reduced LS in SVR patients and relapsers. Significant reduction of LS is associated with milder fibrosis stage, lower hyaluronic acid levels, longer IFN treatment, virological response of SVR or relapse and higher alanine aminotransferase levels.

Keywords: non-virological response; relapser; ribavirin; sustained virological response; transient elastography

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1872-034X.2009.00618.x

Affiliations: 1: Department of Liver, Biliary Tract and Pancreas Diseases, Fujita Health University, 2: Department of Gastroenterology, Kainan Hospital, Aichi and 3: Cancer Immunotherapy Center, Nagoya Kyoritsu Hospital, Nagoya, Japan

Publication date: April 1, 2010

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more